Cleared Traditional

K192247 - Steripath Gen2 Blood Collection System (FDA 510(k) Clearance)

Feb 2020
Decision
193d
Days
Class 2
Risk

K192247 is an FDA 510(k) clearance for the Steripath Gen2 Blood Collection System. This device is classified as a Tubes, Vials, Systems, Serum Separators, Blood Collection (Class II - Special Controls, product code JKA).

Submitted by Magnolia Medical Technologies, Inc. (Seattle, US). The FDA issued a Cleared decision on February 28, 2020, 193 days after receiving the submission on August 19, 2019.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 862.1675.

Submission Details

510(k) Number K192247 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 2019
Decision Date February 28, 2020
Days to Decision 193 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code JKA - Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1675

Similar Devices - JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 19
BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection Tubes
K252040 · Becton, Dickinson and Company · Mar 2026
Steripath® Flow™ Blood Collection System
K251812 · Magnolia Medical Technologies · Sep 2025
BD Vacutainer® Eclipse™ Blood Collection Needle
K243207 · Becton, Dickinson and Company · Jul 2025
Blood collection tube holders
K250961 · Promisemed Hangzhou Meditech Co., Ltd. · Jun 2025
Navi™ Needle-free Blood Collection Device (VNC20500FG, VNC22500FG, VNC24500FG)
K244047 · Venocare, Inc. · May 2025
BD Vacutainer® Multiple Sample Luer Adapter
K243649 · Becton, Dickinson and Company · Mar 2025